ArticleBlood advances2025

Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.

Joseph Pidala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.